Amida Care Responds to Newest CDC Data, Urges Further Action to Expand Access to PrEP
(New York – July 29, 2019) Doug Wirth, President and CEO of Amida Care, released the following statement in response to the latest data from the Centers for Disease Control (CDC), showing that despite progress, the use of pre-exposure prophylaxis (PrEP) among men at elevated risk for HIV remains low.